Literature DB >> 25612779

Long-term outcome of encapsulating peritoneal sclerosis (EPS) patients in a single center.

Aya Yamahatsu1, Chieko Hamada1, Kayo Kaneko1, Hiroaki Io1, Junichiro Nakata1, Yasuhiko Tomino2.   

Abstract

BACKGROUND: Encapsulating peritoneal sclerosis (EPS) is the most serious complication of peritoneal dialysis (PD) with a high mortality rate. The objective of the present study was to determine the clinical characteristics, the incidence rate, and the long-term outcome of EPS patients compared with control patients.
METHODS: Two hundred and seventy patients with end-stage kidney disease were started on PD from 1987 to 2013 in the Juntendo University Hospital. EPS was diagnosed by clinical findings, radiological findings, and macroscopic inspection at the time of laparoscopy or surgical operation. Patient medical records were analyzed retrospectively, including clinical characteristics, laboratory findings, treatment modality, and outcomes. Using a Kaplan-Meier analysis, we compared the survival rate between EPS patients and control PD patients, matched for age, gender, diabetes, and duration of PD.
RESULTS: Among 270 PD patients, 13 patients (4.8 %) developed EPS. The mean duration of PD was 120.5 ± 42.8 months. There were no significant difference in demographic findings between EPS and control PD patients. Among the EPS patients, seven patients died, of which four deaths were directly attributed to EPS. All four patients that had had surgical enterolysis were doing well and had no recurrences. No significant difference in the survival rate between EPS and control PD patients was observed in the Kaplan-Meier analysis.
CONCLUSIONS: There was no significant difference in the survival rate between EPS patients and control PD patients. It appears that an early diagnosis by laparoscopy and accurate treatment, including surgical enterolysis, might improve mortality.

Entities:  

Keywords:  Encapsulating peritoneal sclerosis; Enterolysis; Laparoscopy; Long-term outcome; Peritoneal dialysis

Mesh:

Substances:

Year:  2015        PMID: 25612779     DOI: 10.1007/s10157-015-1081-7

Source DB:  PubMed          Journal:  Clin Exp Nephrol        ISSN: 1342-1751            Impact factor:   2.801


  23 in total

Review 1.  Recommendations on the management of encapsulating peritoneal sclerosis in Japan, 2005: diagnosis, predictive markers, treatment, and preventive measures.

Authors:  Yoshindo Kawaguchi; Akira Saito; Hideki Kawanishi; Masaaki Nakayama; Masanobu Miyazaki; Hidetomo Nakamoto; Anders Tranaeus
Journal:  Perit Dial Int       Date:  2005-04       Impact factor: 1.756

2.  Surgical techniques for prevention of recurrence after total enterolysis in encapsulating peritoneal sclerosis.

Authors:  Hideki Kawanishi; Kentaro Ide; Masahiko Yamashita; Manabu Shimomura; Misaki Moriishi; Shinichiro Tsuchiya; Kiyohiko Dohi
Journal:  Adv Perit Dial       Date:  2008

3.  Length of time on peritoneal dialysis and encapsulating peritoneal sclerosis: position paper for ISPD.

Authors:  Edwina A Brown; Wim Van Biesen; Fredric O Finkelstein; Helen Hurst; David W Johnson; Hideki Kawanishi; Roberto Pecoits-Filho; Graham Woodrow
Journal:  Perit Dial Int       Date:  2009 Nov-Dec       Impact factor: 1.756

4.  Successful surgical management of encapsulating peritoneal sclerosis.

Authors:  Hideki Kawanishi; Hiroshi Watanabe; Misaki Moriishi; Shinichiro Tsuchiya
Journal:  Perit Dial Int       Date:  2005-04       Impact factor: 1.756

5.  Efficacy and morbidity of surgical therapy in late-stage encapsulating peritoneal sclerosis.

Authors:  Christoph Ulmer; Niko Braun; Fabian Rieber; Joerg Latus; Sandra Hirschburger; Jens Emmel; M Dominik Alscher; Wolfgang Steurer; Klaus-Peter Thon
Journal:  Surgery       Date:  2012-09-14       Impact factor: 3.982

6.  Encapsulating peritoneal sclerosis: incidence, predictors, and outcomes.

Authors:  David W Johnson; Yeoungjee Cho; Brian E R Livingston; Carmel M Hawley; Stephen P McDonald; Fiona G Brown; Johan B Rosman; Kym M Bannister; Kathryn J Wiggins
Journal:  Kidney Int       Date:  2010-03-10       Impact factor: 10.612

7.  Sclerosing encapsulating peritonitis in patients undergoing continuous ambulatory peritoneal dialysis: a report of the Japanese Sclerosing Encapsulating Peritonitis Study Group.

Authors:  Y Nomoto; Y Kawaguchi; H Kubo; H Hirano; S Sakai; K Kurokawa
Journal:  Am J Kidney Dis       Date:  1996-09       Impact factor: 8.860

8.  Assessing the validity of an abdominal CT scoring system in the diagnosis of encapsulating peritoneal sclerosis.

Authors:  Ruth M Tarzi; Adrian Lim; Steven Moser; Sohail Ahmad; Abraham George; Gowrie Balasubramaniam; Elaine J Clutterbuck; Wladyslaw Gedroyc; Edwina A Brown
Journal:  Clin J Am Soc Nephrol       Date:  2008-07-30       Impact factor: 8.237

9.  Encapsulating peritoneal sclerosis in patients on peritoneal dialysis in Slovenia.

Authors:  Jelka Lindic; Alijana Trost Rupnik; Janez Tomazic; Andrej Skoberne; Andrej Gucek; Dusan Ferluga; Tadeja Pintar; Andreja Ales; Damjan Kovac; Radoslav Kveder; Jernej Pajek; Barbara Savicki-Ponikvar; Andrej Bren
Journal:  Ther Apher Dial       Date:  2009-08       Impact factor: 1.762

10.  Risk factors for developing encapsulating peritoneal sclerosis in the icodextrin era of peritoneal dialysis prescription.

Authors:  Anne-Marie Habib; Emma Preston; Andrew Davenport
Journal:  Nephrol Dial Transplant       Date:  2009-12-27       Impact factor: 5.992

View more
  4 in total

1.  Morphologic characteristics of macroscopic peritoneal finding in patients with peritoneal dialysis.

Authors:  Chieko Hamada; Hirotaka Nakamoto; Yusuke Suzuki
Journal:  J Artif Organs       Date:  2017-10-07       Impact factor: 1.731

2.  Incidence and outcomes of encapsulating peritoneal sclerosis (EPS) and factors associated with severe EPS.

Authors:  Chin-Chung Tseng; Jin-Bor Chen; I-Kuan Wang; Shang-Chih Liao; Ben-Chung Cheng; An-Bang Wu; Yu-Tzu Chang; Shih-Yuan Hung; Chiu-Ching Huang
Journal:  PLoS One       Date:  2018-01-02       Impact factor: 3.240

3.  Risk factors of severe peritoneal sclerosis in chronic peritoneal dialysis patients.

Authors:  Sudabeh Alatab; Iraj Najafi; Gholamreza Pourmand; Mostafa Hosseini; Soroosh Shekarchian
Journal:  Ren Fail       Date:  2016-10-24       Impact factor: 2.606

Review 4.  Risk factors for Encapsulating Peritoneal Sclerosis in patients undergoing peritoneal dialysis: A meta-analysis.

Authors:  Dashan Li; Yuanyuan Li; Hanxu Zeng; Yonggui Wu
Journal:  PLoS One       Date:  2022-03-21       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.